Good points. I think you've also got to factor in the financials...

First 18 Last

Share
Profile

Follow
orlais

113 Posts.

1

13/02/19

16:30

Post #: 37426205
Share

Originally posted by Sojourner: ↑

The initial reluctance appears to simply stem from it being a new product. Everything I've read and heard, including in this conference call is that surgeons are just taking a really cautious approach to this.

Basically they pick a patient, the most ideal patient to trial the product see how it goes. Then they might pick other patients with different characteristics to see how it goes.. and then once they see the consistently good results - they adopt. As you can see, this is creates long lead times.

Ironically I think the problem stems from its initial success for the launch of its product which achieved a 20% market share in six months. This probably led them to believe they could achieve similar success in the U.S.

However, as we now know, the U.S market and the behaviour of surgeons there is clearly different and much more risk averse (I am guessing because of the much more litigious nature of its people).

What I suspect is that the community of surgeons in Oz is much smaller - and so you only need to get success through a few influential surgeons to quickly build market share.

The U.S however is a huge market, but what it means is that it is also difficult to quickly build that kind of trust as there are many competing products and leaders out there.

Expand

Good points. I think you've also got to factor in the financials on the health provider side of things (revenue implications, surgeon commissions etc.) and general resistance to change.

AXP Price at posting: 3.6¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

First 18 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.1¢		Change 0.000(0.00%)		Mkt cap ! $6.684M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
11	29583410	0.1¢

Sellers (Offers)

Price($)	Vol.	No.
0.2¢	80701935	40

View Market Depth

No.	Vol.	Price($)
11	29583410	0.001
0	0	0.000
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.002	80701935	40
0.003	30008309	16
0.004	13166247	13
0.005	5638870	16
0.006	18031191	7

Last trade - 16.00pm 20/06/2025 (20 minute delay)

AXP (ASX) Chart

Day chart unavailable

Good points. I think you've also got to factor in the financials...

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Good points. I think you've also got to factor in the financials...

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News